5-(4-chlorophenyl)-1-(2,3-dichlorophenyl)-2,3-dihydro-1H-imidazole-2-thione, 97%, 100mg

(5-Amino-2-bromo-4-pyridyl)methanol, 98%, 100mg

5-(Methoxymethyl)-1,3,4-thiadiazol-2-amine, 95.0%, 5g

5-Chloro-2-ethoxy-nicotinic acid, 95.0%, 1g

1-(4,6-Dimethoxypyrimidin-2-yl)urea, 98%, 250mg

2-(4-Chlorophenoxy)acetohydrazide, 95.0%, 100g

(2-Bromoethyl)diphenylsulfonium trifluoromethanesulfonate, 97%, 10g

Cuba de muestra ROTILABO® con tapa a presión, 300 ml, no estéril, 240 pieza(s)

N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide, 95.0%, 1g

4-(1h-Pyrazol-3-yl)phenol, 95+%, 1g

4-Cyclopentylpiperazin-1-amine, 95.0%, 10g

3-Aminopentanedioic acid, 95.0%, 250mg

7H-Pyrrolo[2,3-d]pyrimidin-4-amine>97.0%(HPLC)(T)5g